• Roberta H Baron, Jane V Fey, Sara Raboy, Howard T Thaler, Patrick I Borgen, Larissa K F Temple, and Kimberly J Van Zee.
• Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. baronr@mskcc.org
• Oncol Nurs Forum. 2002 May 1;29(4):651-9.

Purpose/ObjectivesTo evaluate prevalence, severity, and level of distress of 18 sensations at 3-15 days (baseline), 3 months, and 6 months after breast cancer surgery; to compare sentinel lymph node biopsy (SLNB) to SLNB with immediate or delayed axillary lymph node dissection; to evaluate the Breast Sensation Assessment Scale(c) (BSAS(c)) for reliability and validity.DesignProspective, descriptive.SettingEvelyn H. Lauder Ambulatory Breast Center at Memorial Sloan-Kettering Cancer Center in New York City.Sample283 women with breast cancer; 187 had SLNB, and 96 had SLNB and axillary lymph node dissection.MethodsPatients completed the BSAS(c) at baseline, three months, and six months after surgery.Main Research VariablesPrevalence, severity, and level of distress of sensations in patients who had breast cancer surgery.FindingsSensations were less prevalent, severe, and distressing following SLNB compared with axillary lymph node dissection at all three time points. Tenderness and soreness remained highly prevalent following SLNB at the three time points. Tenderness, soreness, tightness, and numbness were among the most severe and distressing symptoms in both groups. The BSAS(c) demonstrated good reliability and validity.ConclusionsOverall prevalence, severity, and level of distress were lower following SLNB compared with axillary lymph node dissection at baseline, three months, and six months after surgery. Certain sensations remained prevalent, severe, and distressing in both groups. The BSAS(c) is a reliable and valid instrument.Implications For NursingNurses should be familiar with prevalent sensations patients experience after SLNB and axillary lymph node dissection so they can provide education and support.

26 keywords...

hide…